CXCR4 VLP for Immunization | Case Study

Download this case study to learn how KACTUS successfully used a CXCR4 virus-like particle (VLP) to generate potent anti-CXCR4 monoclonal antibodies. CXCR4 is a GPCR overexpressed in more than 20 cancer types, making it a critical therapeutic target in oncology.